Analyst Ratings for Edgewise Therapeutics (EWTX) [Buys]
EWTX Rating Summary
EWTX Price Target Summary
- Highest: $48.00 (Piper Sandler)
- Lowest: $23.00 (Wedbush)
- Average: $30.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$30.40 (+90.7%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
Avg. $ Target:
$30.40 (+90.7%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/7/2024 | Piper Sandler | Yasmeen Rahimi | New Coverage | Overweight (N/A) |
48.00 (N/A) |
16.97 (15.94) |
-6.07% | Details |
| 5/1/2023 | Truist Securities | Srikripa Devarakonda | New Coverage | Buy (N/A) |
25.00 (N/A) |
8.77 (15.94) |
81.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
